Current Situation of Acute Rheumatic Fever and Rheumatic Heart Disease in Latin America and the Caribbean: A

Maria Alejandra Jaimes-Reyes1, Manuel Urina-Jassir1, Manuel Urina-Triana1,2

  • 1Fundación del Caribe para la Investigación Biomédica, Carrera 50 # 80-216 Office 201, Barranquilla, Atlántico, Colombia.

Global Heart
|October 6, 2022
PubMed

Insights

Rheumatic heart disease (RHD) research in Latin America and the Caribbean (LAC) is limited, with most studies from Brazil. More data is needed from other LAC countries to guide RHD prevention and screening strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Rheumatic heart disease (RHD) disproportionately impacts low- and middle-income nations.
  • The Latin America and Caribbean (LAC) region is underrepresented in RHD scientific literature.
  • Limited data exists on RHD epidemiology, burden, and control strategies in LAC.

Purpose of the Study:

  • To describe the epidemiology and burden of RHD in LAC.
  • To identify implemented screening and prevention strategies for RHD in the LAC region.
  • To highlight research gaps in RHD within LAC.

Main Methods:

  • Systematic literature search of PubMed, Embase, LILACS, and SciELO (1990-2021).
  • Inclusion of observational and experimental studies on RHD epidemiology, burden, or prevention/screening.
  • Data extraction on epidemiology, burden, and preventive strategies; risk of bias assessment.

Main Results:

  • 48 studies met eligibility criteria, predominantly from Brazil and hospital-based.
  • ARF epidemiology data is dated; RHD prevalence varied (0.24-48/1000 schoolchildren).
  • RHD burden studies reported mortality and complications; six preventive strategies and three screening studies were identified.

Conclusions:

  • Most ARF/RHD research and preventive efforts are concentrated in Brazil.
  • A significant data paucity exists from other LAC countries.
  • Further epidemiological studies across LAC are crucial for effective RHD prevention and control.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
31
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
46
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
26
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
33
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
19